Treatment of HIV infection with once-daily regimens

By Permpalung Nitipong   Putcharoen Opass   Avihingsanon Anchalee   Ruxrungtham Kiat  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 16, 2012-11 ,pp. : 2301-2317

Informa Healthcare

Access to resources Recommend Favorite

Long-Term Efficacy and Safety of Efavirenz Dose Reduction to 200 mg Once Daily in a Caucasian Patient with HIV

By >   Gómez Alicia Iglesias  

Clinical Drug Investigation, Vol. 30, Iss. 6, 2010-06 ,pp. : 405-411

Adis International

Access to resources Recommend Favorite

Elvitegravir: a once-daily inhibitor of HIV-1 integrase

By Wills Todd   Vega Vivian  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 3, 2012-03 ,pp. : 395-401

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Tolerability of Once-Daily Grepafloxacin Compared with Clarithromycin in the Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis

By deAbate C.A.  

Clinical Drug Investigation, Vol. 18, Iss. 3, 1999-09 ,pp. : 243-253

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Once-Daily Grepafloxacin Compared with Clarithromycin in the Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis

By deAbate C.A.  

Clinical Drug Investigation, Vol. 17, Iss. 1, 1999-01 ,pp. : 21-31

Adis International

Access to resources Recommend Favorite